<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Cleo Diagnostics Ltd — News on 6ix</title>
    <link>https://6ix.com/company/cleo-diagnostics-ltd</link>
    <description>Latest news and press releases for Cleo Diagnostics Ltd on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Tue, 28 Apr 2026 02:47:15 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/cleo-diagnostics-ltd" rel="self" type="application/rss+xml" />
    <item>
      <title>CLEO Commences Kit Manufacturing Ahead of FDA Submission</title>
      <link>https://6ix.com/company/cleo-diagnostics-ltd/news/cleo-commences-kit-manufacturing-ahead-of-fda-submission</link>
      <guid isPermaLink="true">https://6ix.com/company/cleo-diagnostics-ltd/news/cleo-commences-kit-manufacturing-ahead-of-fda-submission</guid>
      <pubDate>Tue, 28 Apr 2026 02:47:15 GMT</pubDate>
      <description>CLEO Commences Kit Manufacturing Ahead of FDA Submission</description>
    </item>
    <item>
      <title>Sample Collection Completion for Pivotal US Clinical Trial</title>
      <link>https://6ix.com/company/cleo-diagnostics-ltd/news/sample-collection-completion-for-pivotal-us-clinical-trial</link>
      <guid isPermaLink="true">https://6ix.com/company/cleo-diagnostics-ltd/news/sample-collection-completion-for-pivotal-us-clinical-trial</guid>
      <pubDate>Tue, 31 Mar 2026 02:25:06 GMT</pubDate>
      <description>Sample Collection Completion for Pivotal US Clinical Trial</description>
    </item>
    <item>
      <title>CLEO Optimises Biomarker Panel Ahead of FDA Submission</title>
      <link>https://6ix.com/company/cleo-diagnostics-ltd/news/cleo-optimises-biomarker-panel-ahead-of-fda-submission</link>
      <guid isPermaLink="true">https://6ix.com/company/cleo-diagnostics-ltd/news/cleo-optimises-biomarker-panel-ahead-of-fda-submission</guid>
      <pubDate>Mon, 23 Mar 2026 01:50:04 GMT</pubDate>
      <description>CLEO Optimises Biomarker Panel Ahead of FDA Submission</description>
    </item>
    <item>
      <title>Appendix 4D and Half Yearly Accounts</title>
      <link>https://6ix.com/company/cleo-diagnostics-ltd/news/appendix-4d-and-half-yearly-accounts-4</link>
      <guid isPermaLink="true">https://6ix.com/company/cleo-diagnostics-ltd/news/appendix-4d-and-half-yearly-accounts-4</guid>
      <pubDate>Wed, 25 Feb 2026 10:45:11 GMT</pubDate>
      <description>Appendix 4D and Half Yearly Accounts</description>
    </item>
    <item>
      <title>CLEO Confirms Next-Gen Platform for Ovarian Cancer Test</title>
      <link>https://6ix.com/company/cleo-diagnostics-ltd/news/cleo-confirms-next-gen-platform-for-ovarian-cancer-test</link>
      <guid isPermaLink="true">https://6ix.com/company/cleo-diagnostics-ltd/news/cleo-confirms-next-gen-platform-for-ovarian-cancer-test</guid>
      <pubDate>Wed, 18 Feb 2026 04:05:10 GMT</pubDate>
      <description>CLEO Confirms Next-Gen Platform for Ovarian Cancer Test</description>
    </item>
    <item>
      <title>Quarterly activities and cashflow report</title>
      <link>https://6ix.com/company/cleo-diagnostics-ltd/news/quarterly-activities-and-cashflow-report-52</link>
      <guid isPermaLink="true">https://6ix.com/company/cleo-diagnostics-ltd/news/quarterly-activities-and-cashflow-report-52</guid>
      <pubDate>Thu, 29 Jan 2026 02:45:08 GMT</pubDate>
      <description>Quarterly activities and cashflow report</description>
    </item>
    <item>
      <title>CLEO Raises $5m to Support U.S. Market Launch</title>
      <link>https://6ix.com/company/cleo-diagnostics-ltd/news/cleo-raises-dollar5m-to-support-us-market-launch</link>
      <guid isPermaLink="true">https://6ix.com/company/cleo-diagnostics-ltd/news/cleo-raises-dollar5m-to-support-us-market-launch</guid>
      <pubDate>Thu, 18 Dec 2025 04:14:06 GMT</pubDate>
      <description>CLEO Raises $5m to Support U.S. Market Launch</description>
    </item>
    <item>
      <title>Trading Halt</title>
      <link>https://6ix.com/company/cleo-diagnostics-ltd/news/trading-halt-697</link>
      <guid isPermaLink="true">https://6ix.com/company/cleo-diagnostics-ltd/news/trading-halt-697</guid>
      <pubDate>Wed, 17 Dec 2025 03:11:05 GMT</pubDate>
      <description>Trading Halt</description>
    </item>
    <item>
      <title>Cleo Strengthens Cash Position with $1.7m R&amp;D Tax Refund</title>
      <link>https://6ix.com/company/cleo-diagnostics-ltd/news/cleo-strengthens-cash-position-with-dollar17m-randd-tax-refund</link>
      <guid isPermaLink="true">https://6ix.com/company/cleo-diagnostics-ltd/news/cleo-strengthens-cash-position-with-dollar17m-randd-tax-refund</guid>
      <pubDate>Wed, 26 Nov 2025 02:45:13 GMT</pubDate>
      <description>Cleo Strengthens Cash Position with $1.7m R&amp;D Tax Refund</description>
    </item>
    <item>
      <title>CLEO Appoints First Key Opinion Leader to Support US Market</title>
      <link>https://6ix.com/company/cleo-diagnostics-ltd/news/cleo-appoints-first-key-opinion-leader-to-support-us-market</link>
      <guid isPermaLink="true">https://6ix.com/company/cleo-diagnostics-ltd/news/cleo-appoints-first-key-opinion-leader-to-support-us-market</guid>
      <pubDate>Wed, 19 Nov 2025 04:23:10 GMT</pubDate>
      <description>CLEO Appoints First Key Opinion Leader to Support US Market</description>
    </item>
    <item>
      <title>CLEO Significantly Expands Addressable Market</title>
      <link>https://6ix.com/company/cleo-diagnostics-ltd/news/cleo-significantly-expands-addressable-market</link>
      <guid isPermaLink="true">https://6ix.com/company/cleo-diagnostics-ltd/news/cleo-significantly-expands-addressable-market</guid>
      <pubDate>Thu, 06 Nov 2025 03:40:10 GMT</pubDate>
      <description>CLEO Significantly Expands Addressable Market</description>
    </item>
    <item>
      <title>CLEO Successfully Completes Stage 1 MDSAP Audit</title>
      <link>https://6ix.com/company/cleo-diagnostics-ltd/news/cleo-successfully-completes-stage-1-mdsap-audit</link>
      <guid isPermaLink="true">https://6ix.com/company/cleo-diagnostics-ltd/news/cleo-successfully-completes-stage-1-mdsap-audit</guid>
      <pubDate>Thu, 30 Oct 2025 03:04:20 GMT</pubDate>
      <description>CLEO Successfully Completes Stage 1 MDSAP Audit</description>
    </item>
    <item>
      <title>Cleo Receives Positive FDA Feedback</title>
      <link>https://6ix.com/company/cleo-diagnostics-ltd/news/cleo-receives-positive-fda-feedback</link>
      <guid isPermaLink="true">https://6ix.com/company/cleo-diagnostics-ltd/news/cleo-receives-positive-fda-feedback</guid>
      <pubDate>Mon, 15 Sep 2025 03:50:34 GMT</pubDate>
      <description>Cleo Receives Positive FDA Feedback</description>
    </item>
    <item>
      <title>Appendix 4E and 2025 Annual Report</title>
      <link>https://6ix.com/company/cleo-diagnostics-ltd/news/appendix-4e-and-2025-annual-report-35</link>
      <guid isPermaLink="true">https://6ix.com/company/cleo-diagnostics-ltd/news/appendix-4e-and-2025-annual-report-35</guid>
      <pubDate>Tue, 26 Aug 2025 11:08:15 GMT</pubDate>
      <description>Appendix 4E and 2025 Annual Report</description>
    </item>
    <item>
      <title>COV Commences Health Economic Study-Support US Market Entry</title>
      <link>https://6ix.com/company/cleo-diagnostics-ltd/news/cov-commences-health-economic-study-support-us-market-entry</link>
      <guid isPermaLink="true">https://6ix.com/company/cleo-diagnostics-ltd/news/cov-commences-health-economic-study-support-us-market-entry</guid>
      <pubDate>Mon, 18 Aug 2025 03:43:35 GMT</pubDate>
      <description>COV Commences Health Economic Study-Support US Market Entry</description>
    </item>
    <item>
      <title>CLEO Strengthens FDA Submission - Access to US Biobank</title>
      <link>https://6ix.com/company/cleo-diagnostics-ltd/news/cleo-strengthens-fda-submission-access-to-us-biobank</link>
      <guid isPermaLink="true">https://6ix.com/company/cleo-diagnostics-ltd/news/cleo-strengthens-fda-submission-access-to-us-biobank</guid>
      <pubDate>Wed, 25 Jun 2025 04:19:13 GMT</pubDate>
      <description>CLEO Strengthens FDA Submission - Access to US Biobank</description>
    </item>
    <item>
      <title>Corporate Presentation</title>
      <link>https://6ix.com/company/cleo-diagnostics-ltd/news/corporate-presentation-30</link>
      <guid isPermaLink="true">https://6ix.com/company/cleo-diagnostics-ltd/news/corporate-presentation-30</guid>
      <pubDate>Thu, 12 Jun 2025 02:54:14 GMT</pubDate>
      <description>Corporate Presentation</description>
    </item>
    <item>
      <title>Cleo Advances with Completion of Alpha Testing</title>
      <link>https://6ix.com/company/cleo-diagnostics-ltd/news/cleo-advances-with-completion-of-alpha-testing</link>
      <guid isPermaLink="true">https://6ix.com/company/cleo-diagnostics-ltd/news/cleo-advances-with-completion-of-alpha-testing</guid>
      <pubDate>Mon, 12 May 2025 04:38:13 GMT</pubDate>
      <description>Cleo Advances with Completion of Alpha Testing</description>
    </item>
    <item>
      <title>CLEO to Fast Track Development of Ovarian Cancer Test</title>
      <link>https://6ix.com/company/cleo-diagnostics-ltd/news/cleo-to-fast-track-development-of-ovarian-cancer-test</link>
      <guid isPermaLink="true">https://6ix.com/company/cleo-diagnostics-ltd/news/cleo-to-fast-track-development-of-ovarian-cancer-test</guid>
      <pubDate>Mon, 28 Apr 2025 03:30:13 GMT</pubDate>
      <description>CLEO to Fast Track Development of Ovarian Cancer Test</description>
    </item>
    <item>
      <title>CLEO Receives A$845k Research and Development Tax Incentive</title>
      <link>https://6ix.com/company/cleo-diagnostics-ltd/news/cleo-receives-adollar845k-research-and-development-tax-incentive</link>
      <guid isPermaLink="true">https://6ix.com/company/cleo-diagnostics-ltd/news/cleo-receives-adollar845k-research-and-development-tax-incentive</guid>
      <pubDate>Thu, 24 Apr 2025 05:36:03 GMT</pubDate>
      <description>CLEO Receives A$845k Research and Development Tax Incentive</description>
    </item>
  </channel>
</rss>